Summary
CVS Caremark Corporation's 2008 10-K filing highlights a significant year of strategic expansion and operational integration. The company completed the acquisition of Longs Drug Stores Corporation, bolstering its retail presence and adding pharmacy benefit management (PBM) capabilities through RxAmerica. This follows the transformative Caremark merger in 2007, which established CVS Caremark as a fully integrated pharmacy services provider. The company operates through two main segments: Pharmacy Services, offering PBM, mail order, and specialty pharmacy services, and Retail Pharmacy, encompassing its extensive network of CVS/pharmacy and Longs Drug stores and MinuteClinics. Financially, the company reported substantial net revenues, driven by strong performance in both segments. The Retail Pharmacy segment continues to be a core driver, with prescription drugs accounting for 68% of its revenues. The Pharmacy Services segment manages a significant volume of prescriptions, benefiting from scale and integration. Management emphasizes a strategy focused on innovation, cost management, and customer service across both segments. Key initiatives include programs like Proactive Pharmacy Care™ and the ExtraCare® loyalty program, aimed at enhancing customer engagement and clinical outcomes. Despite the strategic successes, the filing also outlines significant risks, including economic downturns impacting consumer spending and drug utilization, potential challenges in integrating acquisitions, increasing government regulation in the healthcare sector, and intense competition. The company's robust strategy and established market position appear to be navigating these complexities, as evidenced by continued store development and PBM client renewals.
Financial Highlights
56 data points| Revenue | $87.47B |
| Cost of Revenue | $69.18B |
| Gross Profit | $18.29B |
| Operating Expenses | $12.24B |
| Operating Income | $6.05B |
| Interest Expense | $530.00M |
| Net Income | $3.20B |
| EPS (Basic) | $2.23 |
| EPS (Diluted) | $2.18 |
| Shares Outstanding (Basic) | 1.43B |
| Shares Outstanding (Diluted) | 1.47B |
Key Highlights
- 1Acquisition of Longs Drug Stores Corporation, significantly expanding the retail footprint and PBM capabilities.
- 2Successful integration of the 2007 Caremark merger, creating a fully integrated pharmacy services company.
- 3Strong revenue generation driven by both the Retail Pharmacy segment (68% of revenue from prescription drugs) and the Pharmacy Services segment (managing over 633 million prescriptions in 2008).
- 4Strategic focus on innovation, including programs like Proactive Pharmacy Care™ and the ExtraCare® loyalty program, to drive customer engagement and loyalty.
- 5Expansion of retail presence with 188 new stores opened in 2008, alongside 529 acquired stores from Longs.
- 6Operates 6,923 retail drugstores and 560 MinuteClinics across 41 states and D.C., holding significant market share in key markets.
- 7Navigating a complex regulatory environment, including increased scrutiny on PBM practices and Medicare Part D program management.